Status:
COMPLETED
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
7-11 years
Phase:
NA
Brief Summary
The purpose of this study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disord...
Detailed Description
ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development. The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type. Unfortunately...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- ADHD, Predominantly Inattentive Type
- Public or private school attendance
- English speaking
Exclusion
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00071656
Start Date
September 1 2002
End Date
June 1 2007
Last Update
August 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HALP Clinic, Children's Center at Langley Porter, UCSF
San Francisco, California, United States, 94143